{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T02:58:32Z","timestamp":1777431512732,"version":"3.51.4"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000291","name":"Kidney Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000291","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Peripheral tolerance prevents the initiation of damaging immune responses by autoreactive lymphocytes. While tolerogenic mechanisms are tightly regulated by antigen-dependent and independent signals, downstream pathways are incompletely understood. N-myc downstream-regulated gene 1 (NDRG1), an anti-cancer therapeutic target, has previously been implicated as a CD4<jats:sup>+<\/jats:sup>T cell clonal anergy factor. By RNA-sequencing, we identified<jats:italic>Ndrg1<\/jats:italic>as the third most upregulated gene in anergic, compared to na\u00efve follicular, B cells.<jats:italic>Ndrg1<\/jats:italic>is upregulated by B cell receptor activation (signal one) and suppressed by co-stimulation (signal two), suggesting that NDRG1 may be important in B cell tolerance. However, though<jats:italic>Ndrg1<\/jats:italic><jats:sup><jats:italic>\u2212\/\u2212<\/jats:italic><\/jats:sup>mice have a neurological defect mimicking NDRG1-associated Charcot-Marie-Tooth (CMT4d) disease, primary and secondary immune responses were normal. We find that B cell tolerance is maintained, and NDRG1 does not play a role in downstream responses during re-stimulation of in vivo antigen-experienced CD4<jats:sup>+<\/jats:sup>T cells, demonstrating that NDGR1 is functionally redundant for lymphocyte anergy.<\/jats:p>","DOI":"10.1038\/s42003-022-04118-w","type":"journal-article","created":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T19:04:51Z","timestamp":1668107091000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["NDRG1 is induced by antigen-receptor signaling but dispensable for B and T cell self-tolerance"],"prefix":"10.1038","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9157-045X","authenticated-orcid":false,"given":"Rose","family":"Hodgson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xijin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4528-0651","authenticated-orcid":false,"given":"Consuelo","family":"Anzilotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8543-6801","authenticated-orcid":false,"given":"Mukta","family":"Deobagkar-Lele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya L.","family":"Crockford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica D.","family":"Kepple","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleanor","family":"Cawthorne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aneesha","family":"Bhandari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4737-0215","authenticated-orcid":false,"given":"Alberto","family":"Cebrian-Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin J.","family":"Wilcock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6213-3269","authenticated-orcid":false,"given":"Richard J.","family":"Cornall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0656-0917","authenticated-orcid":false,"given":"Katherine R.","family":"Bull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,10]]},"reference":[{"key":"4118_CR1","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1073\/pnas.77.3.1602","volume":"77","author":"GJV Nossal","year":"1980","unstructured":"Nossal, G. J. V. & Pike, B. L. Clonal anergy: persistence in tolerant mice of antigen-binding B lymphocytes incapable of responding to antigen or mitogen. Proc. Natl Acad. Sci. USA. 77, 1602\u20131606 (1980).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"4118_CR2","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1101\/SQB.1989.054.01.072","volume":"54","author":"RH Schwartz","year":"1989","unstructured":"Schwartz, R. H., Mueller, D. L., Jenkins, M. K. & Quill, H. T-cell clonal anergy. Cold Spring Harb. Symp. Quant. Biol. 54, 605\u2013610 (1989).","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"4118_CR3","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1097\/01.tp.0000203830.79357.39","volume":"81","author":"H Ferry","year":"2006","unstructured":"Ferry, H. et al. B-cell tolerance. Transplantation 81, 308\u2013315 (2006).","journal-title":"Transplantation"},{"key":"4118_CR4","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1146\/annurev.immunol.21.120601.141110","volume":"21","author":"RH Schwartz","year":"2003","unstructured":"Schwartz, R. H. T cell anergy. Annu. Rev. Immunol. 21, 305\u2013334 (2003).","journal-title":"Annu. Rev. Immunol."},{"key":"4118_CR5","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1126\/science.169.3950.1042","volume":"169","author":"P Bretscher","year":"1970","unstructured":"Bretscher, P. & Cohn, M. A theory of self-nonself discrimination. Science 169, 1042\u20131049 (1970).","journal-title":"Science"},{"key":"4118_CR6","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/nri823","volume":"2","author":"AG Baxter","year":"2002","unstructured":"Baxter, A. G. & Hodgkin, P. D. Activation rules: the two-signal theories of immune activation. Nat. Rev. Immunol. 2, 439\u2013446 (2002).","journal-title":"Nat. Rev. Immunol."},{"key":"4118_CR7","doi-asserted-by":"crossref","unstructured":"Bretscher, P. A. A two-step, two-signal model for the primary activation of precursor helper T cells. Proc. Natl. Acad. Sci. USA 96, 185\u2013190 (1999).","DOI":"10.1073\/pnas.96.1.185"},{"key":"4118_CR8","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1600-065X.2010.00936.x","volume":"237","author":"Y Yarkoni","year":"2010","unstructured":"Yarkoni, Y., Getahun, A. & Cambier, J. C. Molecular underpinning of B-cell anergy. Immunol. Rev. 237, 249\u2013263 (2010).","journal-title":"Immunol. Rev."},{"key":"4118_CR9","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/334676a0","volume":"334","author":"CC Goodnow","year":"1988","unstructured":"Goodnow, C. C. et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334, 676\u2013682 (1988).","journal-title":"Nature"},{"key":"4118_CR10","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1084\/jem.179.2.425","volume":"179","author":"MP Cooke","year":"1994","unstructured":"Cooke, M. P. et al. Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells. J. Exp. Med. 179, 425\u2013438 (1994).","journal-title":"J. Exp. Med."},{"key":"4118_CR11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.0105-2896.2006.00370.x","volume":"210","author":"M Borde","year":"2006","unstructured":"Borde, M., Barrington, R. A., Heissmeyer, V., Carroll, M. C. & Rao, A. Transcriptional basis of lymphocyte tolerance. Immunol. Rev. 210, 105\u2013119 (2006).","journal-title":"Immunol. Rev."},{"key":"4118_CR12","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.4049\/jimmunol.177.3.1510","volume":"177","author":"RA Barrington","year":"2006","unstructured":"Barrington, R. A., Borde, M., Rao, A. & Carroll, M. C. Involvement of NFAT1 in B cell self-tolerance. J. Immunol. 177, 1510\u20131515 (2006).","journal-title":"J. Immunol."},{"key":"4118_CR13","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S1074-7613(00)80285-X","volume":"6","author":"JI Healy","year":"1997","unstructured":"Healy, J. I. et al. Different nuclear signals are activated by the B cell receptor during positive versus negative signaling. Immunity 6, 419\u2013428 (1997).","journal-title":"Immunity"},{"key":"4118_CR14","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1146\/annurev.immunol.16.1.645","volume":"16","author":"JI Healy","year":"1998","unstructured":"Healy, J. I. & Goodnow, C. C. Positive versus negative signaling by lymphocyte antigen receptors. Annu. Rev. Immunol. 16, 645\u2013670 (1998).","journal-title":"Annu. Rev. Immunol."},{"key":"4118_CR15","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1084\/jem.191.8.1443","volume":"191","author":"BC Weintraub","year":"2000","unstructured":"Weintraub, B. C. et al. Entry of B cell receptor into signaling domains is inhibited in tolerant B cells. J. Exp. Med. 191, 1443\u20131448 (2000).","journal-title":"J. Exp. Med."},{"key":"4118_CR16","doi-asserted-by":"publisher","first-page":"5337","DOI":"10.4049\/jimmunol.177.8.5337","volume":"177","author":"L Rui","year":"2006","unstructured":"Rui, L., Healy, J. I., Blasioli, J. & Goodnow, C. C. ERK signaling is a molecular switch integrating opposing inputs from B cell receptor and T cell cytokines to control TLR4-driven plasma cell differentiation. J. Immunol. 177, 5337\u20135346 (2006).","journal-title":"J. Immunol."},{"key":"4118_CR17","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S1074-7613(04)00079-2","volume":"20","author":"R Lesley","year":"2004","unstructured":"Lesley, R. et al. Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF. Immunity 20, 441\u2013453 (2004).","journal-title":"Immunity"},{"key":"4118_CR18","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1084\/jem.20030411","volume":"198","author":"A Enders","year":"2003","unstructured":"Enders, A. et al. Loss of the pro-apoptotic BH3-only Bcl-2 family member Bim inhibits BCR stimulation-induced apoptosis and deletion of autoreactive B cells. J. Exp. Med. 198, 1119\u20131126 (2003).","journal-title":"J. Exp. Med."},{"key":"4118_CR19","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/371389a0","volume":"371","author":"JG Cyster","year":"1994","unstructured":"Cyster, J. G., Hartley, S. B. & Goodnow, C. C. Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire. Nature 371, 389\u2013395 (1994).","journal-title":"Nature"},{"key":"4118_CR20","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1084\/jem.183.5.2313","volume":"183","author":"DA Fulcher","year":"1996","unstructured":"Fulcher, D. A. et al. The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help. J. Exp. Med. 183, 2313\u20132328 (1996).","journal-title":"J. Exp. Med."},{"key":"4118_CR21","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1002\/(SICI)1521-4141(199808)28:08<2549::AID-IMMU2549>3.0.CO;2-O","volume":"28","author":"MC Cook","year":"1998","unstructured":"Cook, M. C., Basten, A. & Fazekas De St. Groth, B. Rescue of self-reactive B cells by provision of T cell help in vivo. Eur. J. Immunol. 28, 2549\u20132558 (1998).","journal-title":"Eur. J. Immunol."},{"key":"4118_CR22","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S1074-7613(00)80284-8","volume":"6","author":"VL Perez","year":"1997","unstructured":"Perez, V. L. et al. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 6, 411\u2013417 (1997).","journal-title":"Immunity"},{"key":"4118_CR23","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1093\/intimm\/4.6.661","volume":"4","author":"B Beverly","year":"1992","unstructured":"Beverly, B., Kang, S. M. O., Lenardo, M. J. & Schwartz, R. H. Reversal of in vitro T cell clonal anergy by IL-2 stimulation. Int. Immunol. 4, 661\u2013671 (1992).","journal-title":"Int. Immunol."},{"key":"4118_CR24","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.4049\/jimmunol.176.4.2279","volume":"176","author":"L Chiodetti","year":"2006","unstructured":"Chiodetti, L., Choi, S., Barber, D. L. & Schwartz, R. H. Adaptive tolerance and clonal anergy are distinct biochemical states. J. Immunol. 176, 2279\u20132291 (2006).","journal-title":"J. Immunol."},{"key":"4118_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13381","volume":"7","author":"Z Sabouri","year":"2016","unstructured":"Sabouri, Z. et al. IgD attenuates the IgM-induced anergy response in transitional and mature B cells. Nat. Commun. 7, 13381 (2016).","journal-title":"Nat. Commun."},{"key":"4118_CR26","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1084\/jem.20120342","volume":"209","author":"Y Zheng","year":"2012","unstructured":"Zheng, Y., Zha, Y., Driessens, G., Locke, F. & Gajewski, T. F. Transcriptional regulator early growth response gene 2 (Egr2) is required for T cell anergy in vitro and in vivo. J. Exp. Med. 209, 2157\u20132163 (2012).","journal-title":"J. Exp. Med."},{"key":"4118_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9698","volume":"6","author":"YM Oh","year":"2015","unstructured":"Oh, Y. M. et al. Ndrg1 is a T-cell clonal anergy factor negatively regulated by CD28 costimulation and interleukin-2. Nat. Commun. 6, 8698 (2015).","journal-title":"Nat. Commun."},{"key":"4118_CR28","first-page":"85","volume":"77","author":"N Van Belzen","year":"1997","unstructured":"Van Belzen, N. et al. A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. Lab. Investig. 77, 85\u201392 (1997).","journal-title":"Lab. Investig."},{"key":"4118_CR29","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/carcin\/bgm200","volume":"29","author":"TP Ellen","year":"2008","unstructured":"Ellen, T. P., Ke, Q., Zhang, P. & Costa, M. NDRG1, a growth and cancer related gene: Regulation of gene expression andfunction in normal and disease states. Carcinogenesis 29, 2\u20138 (2008).","journal-title":"Carcinogenesis"},{"key":"4118_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbcan.2013.11.002","volume":"1845","author":"BA Fang","year":"2014","unstructured":"Fang, B. A. et al. Molecular functions of the iron-regulated metastasis suppressor, NDRG1, and its potential as a molecular target for cancer therapy. Biochim. Biophys. Acta - Rev. Cancer 1845, 1\u201319 (2014).","journal-title":"Biochim. Biophys. Acta - Rev. Cancer"},{"key":"4118_CR31","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1093\/carcin\/bgt163","volume":"34","author":"J Sun","year":"2013","unstructured":"Sun, J. et al. Metastasis suppressor, NDRG1, mediates its activity through signaling pathways and molecular motors. Carcinogenesis 34, 1943\u20131954 (2013).","journal-title":"Carcinogenesis"},{"key":"4118_CR32","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00418-002-0460-9","volume":"118","author":"P Lachat","year":"2002","unstructured":"Lachat, P., Shaw, P., Gebhard, S., Nico van Belzen, P. C. & Bosman, F. T. Expression of NDRG1, a differentiation-related gene, in human tissues. Histochem. Cell Biol. 118, 399\u2013408 (2002).","journal-title":"Histochem. Cell Biol."},{"key":"4118_CR33","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1086\/302978","volume":"67","author":"L Kalaydjieva","year":"2000","unstructured":"Kalaydjieva, L. et al. N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom. Am. J. Hum. Genet. 67, 47\u201358 (2000).","journal-title":"Am. J. Hum. Genet."},{"key":"4118_CR34","doi-asserted-by":"publisher","first-page":"3949","DOI":"10.1128\/MCB.24.9.3949-3956.2004","volume":"24","author":"T Okuda","year":"2004","unstructured":"Okuda, T. et al. Ndrg1-deficient mice exhibit a progressive demyelinating disorder of peripheral nerves. Mol. Cell. Biol. 24, 3949\u20133956 (2004).","journal-title":"Mol. Cell. Biol."},{"key":"4118_CR35","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s12253-016-0071-8","volume":"22","author":"X Chang","year":"2016","unstructured":"Chang, X. et al. NDRG1 controls gastric cancer migration and invasion through regulating MMP-9. Pathol. Oncol. Res. 22, 789\u2013796 (2016).","journal-title":"Pathol. Oncol. Res."},{"key":"4118_CR36","doi-asserted-by":"publisher","first-page":"5675","DOI":"10.1038\/sj.onc.1207734","volume":"23","author":"S Bandyopadhyay","year":"2004","unstructured":"Bandyopadhyay, S. et al. Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression. Oncogene 23, 5675\u20135681 (2004).","journal-title":"Oncogene"},{"key":"4118_CR37","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.surg.2010.11.002","volume":"149","author":"E Angst","year":"2011","unstructured":"Angst, E. et al. N-myc downstream regulated gene-1 expression correlates with reduced pancreatic cancer growth and increased apoptosis in vitro and in vivo. Surgery 149, 614\u2013624 (2011).","journal-title":"Surgery"},{"key":"4118_CR38","first-page":"1731","volume":"63","author":"S Bandyopadhyay","year":"2003","unstructured":"Bandyopadhyay, S. et al. The Drg-1 gene suppresses tumor metastasis in prostate cancer. Cancer Res. 63, 1731\u20131736 (2003).","journal-title":"Cancer Res."},{"key":"4118_CR39","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1124\/mol.111.073627","volume":"80","author":"Z Kovacevic","year":"2011","unstructured":"Kovacevic, Z., Chikhani, S., Lovejoy, D. B. & Richardson, D. R. Novel thiosemicarbazone iron chelators induce up-regulation and phosphorylation of the metastasis suppressor N-myc down-stream regulated gene 1: a new strategy for the treatment of pancreatic cancer. Mol. Pharmacol. 80, 598\u2013609 (2011).","journal-title":"Mol. Pharmacol."},{"key":"4118_CR40","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1182\/blood-2004-05-1866","volume":"104","author":"NTV Le","year":"2004","unstructured":"Le, N. T. V. & Richardson, D. R. Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and proliferation. Blood 104, 2967\u20132975 (2004).","journal-title":"Blood"},{"key":"4118_CR41","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1093\/carcin\/bgt401","volume":"35","author":"WJ Lu","year":"2014","unstructured":"Lu, W. J., Chua, M. S. & So, S. K. Suppressing N-Myc downstream regulated gene 1 reactivates senescence signaling and inhibits tumor growth in hepatocellular carcinoma. Carcinogenesis 35, 915\u2013922 (2014).","journal-title":"Carcinogenesis"},{"key":"4118_CR42","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1200\/JCO.2006.05.6564","volume":"24","author":"BZ Ring","year":"2006","unstructured":"Ring, B. Z. et al. Novel prognostic immunohistochemical biomarker panel for estrogen receptor-positive breast cancer. J. Clin. Oncol. 24, 3039\u20133047 (2006).","journal-title":"J. Clin. Oncol."},{"key":"4118_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-37186-2","volume":"9","author":"A Li","year":"2019","unstructured":"Li, A. et al. Upregulation of NDRG1 predicts poor outcome and facilitates disease progression by influencing the EMT process in bladder cancer. Sci. Rep. 9, 1\u201312 (2019).","journal-title":"Sci. Rep."},{"key":"4118_CR44","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/modpathol.3800711","volume":"20","author":"MS Chua","year":"2007","unstructured":"Chua, M. S. et al. Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma. Mod. Pathol. 20, 76\u201383 (2007).","journal-title":"Mod. Pathol."},{"key":"4118_CR45","doi-asserted-by":"crossref","unstructured":"Zhao, T., Meng, Y., Wang, Y. & Wang, W. NDRG1 regulates osteosarcoma cells via mediating the mitochondrial function and CSCs differentiation. J. Orthop. Surg. Res. 16, 364 (2021).","DOI":"10.1186\/s13018-021-02503-5"},{"key":"4118_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/15330338211033074","volume":"20","author":"Z Luo","year":"2021","unstructured":"Luo, Z. et al. MiR-188-3p and miR-133b suppress cell proliferation in human hepatocellular carcinoma via post-transcriptional suppression of NDRG1. Technol. Cancer Res. Treat. 20, 1\u20139 (2021).","journal-title":"Technol. Cancer Res. Treat."},{"key":"4118_CR47","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.immuni.2006.10.017","volume":"25","author":"KT Merrell","year":"2006","unstructured":"Merrell, K. T. et al. Identification of anergic B cells within a wild-type repertoire. Immunity 25, 953\u2013962 (2006).","journal-title":"Immunity"},{"key":"4118_CR48","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1600-065X.1998.tb01246.x","volume":"165","author":"JD Powell","year":"1998","unstructured":"Powell, J. D., Ragheb, J. A., Kitagawa-Sakakida, S. & Schwartz, R. H. Molecular regulation of interleukin-2 expression by CD28 co-stimulation and anergy. Immunol. Rev. 165, 287\u2013300 (1998).","journal-title":"Immunol. Rev."},{"key":"4118_CR49","doi-asserted-by":"crossref","unstructured":"Watari, K. et al. Impaired differentiation of macrophage lineage cells attenuates bone remodeling and inflammatory angiogenesis in Ndrg1 deficient mice. Sci. Rep. 6, (2016).","DOI":"10.1038\/srep19470"},{"key":"4118_CR50","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.immuni.2004.05.012","volume":"20","author":"CG Vinuesa","year":"2004","unstructured":"Vinuesa, C. G. & Goodnow, C. C. Illuminating autoimmune regulators through controlled variation of the mouse genome sequence. Immunity 20, 669\u2013679 (2004).","journal-title":"Immunity"},{"key":"4118_CR51","doi-asserted-by":"publisher","first-page":"48930","DOI":"10.1074\/jbc.M400386200","volume":"279","author":"S Stein","year":"2004","unstructured":"Stein, S. et al. NDRG1 is necessary for p53-dependent apoptosis. J. Biol. Chem. 279, 48930\u201348940 (2004).","journal-title":"J. Biol. Chem."},{"key":"4118_CR52","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/1074-7613(95)90059-4","volume":"3","author":"JG Cyster","year":"1995","unstructured":"Cyster, J. G. & Goodnow, C. C. Antigen-induced exclusion from follicles and anergy are separate and complementary processes that influence peripheral B cell fate. Immunity 3, 691\u2013701 (1995).","journal-title":"Immunity"},{"key":"4118_CR53","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/376181a0","volume":"376","author":"JC Rathmell","year":"1995","unstructured":"Rathmell, J. C. et al. CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+T cells. Nature 376, 181\u2013184 (1995).","journal-title":"Nature"},{"key":"4118_CR54","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/1074-7613(94)90084-1","volume":"1","author":"ER Kearney","year":"1994","unstructured":"Kearney, E. R., Pape, K. A., Loh, D. Y. & Jenkins, M. K. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1, 327\u2013339 (1994).","journal-title":"Immunity"},{"key":"4118_CR55","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1158\/2326-6066.CIR-18-0487","volume":"6","author":"A Young","year":"2018","unstructured":"Young, A., Quandt, Z. & Bluestone, J. A. The balancing act between cancer immunity and autoimmunity in response to immunotherapy. Cancer Immunol. Res. 6, 1445\u20131452 (2018).","journal-title":"Cancer Immunol. Res."},{"key":"4118_CR56","doi-asserted-by":"crossref","unstructured":"Ramos-Casals, M. et al. Immune-related adverse events of checkpoint inhibitors. Nat. Rev. Dis. Prim. 6, 38 (2020).","DOI":"10.1038\/s41572-020-0160-6"},{"key":"4118_CR57","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1177\/1352458519851219","volume":"25","author":"J Killestein","year":"2019","unstructured":"Killestein, J. & van Oosten, B. Emerging safety issues in alemtuzumab-treated MS patients. Mult. Scler. J. 25, 1206\u20131208 (2019).","journal-title":"Mult. Scler. J."},{"key":"4118_CR58","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S0092-8674(02)00767-5","volume":"109","author":"F Maci\u00e1n","year":"2002","unstructured":"Maci\u00e1n, F. et al. Transcriptional mechanisms underlying lymphocyte tolerance. Cell 109, 719\u2013731 (2002).","journal-title":"Cell"},{"key":"4118_CR59","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.4049\/jimmunol.160.10.4719","volume":"160","author":"KA Pape","year":"1998","unstructured":"Pape, K. A., Merica, R., Mondino, A., Khoruts, A. & Jenkins, M. K. Direct evidence that functionally impaired CD4+ T cells persist in vivo following induction of peripheral tolerance. J. Immunol. 160, 4719\u20134729 (1998).","journal-title":"J. Immunol."},{"key":"4118_CR60","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/intimm\/10.3.365","volume":"10","author":"C Koniaras","year":"1998","unstructured":"Koniaras, C., Heath, W. R. & Lew, A. M. T cell unresponsiveness in vitro can be due to activation in vivo. Int. Immunol. 10, 365\u2013369 (1998).","journal-title":"Int. Immunol."},{"key":"4118_CR61","doi-asserted-by":"crossref","unstructured":"Bygrave, A. E. et al. Spontaneous autoimmunity in 129 and C57BL\/6 mice-implications for autoimmunity described in gene-targeted mice. PLoS Biol. 2, e243 (2004).","DOI":"10.1371\/journal.pbio.0020243"},{"key":"4118_CR62","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1006\/geno.2000.6496","volume":"73","author":"RH Zhou","year":"2001","unstructured":"Zhou, R. H. et al. Characterization of the human NDRG gene family: a newly identified member, NDRG4, is specifically expressed in brain and heart. Genomics 73, 86\u201397 (2001).","journal-title":"Genomics"},{"key":"4118_CR63","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1023\/A:1017934810825","volume":"229","author":"X Qu","year":"2002","unstructured":"Qu, X. et al. Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family. Mol. Cell. Biochem. 229, 35\u201344 (2002).","journal-title":"Mol. Cell. Biochem."},{"key":"4118_CR64","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1369\/jhc.7A7323.2007","volume":"56","author":"T Okuda","year":"2007","unstructured":"Okuda, T., Kokame, K. & Miyata, T. Differential expression patterns of NDRG family proteins in the central nervous system. J. Histochem. Cytochem. 56, 175\u2013182 (2007).","journal-title":"J. Histochem. Cytochem."},{"key":"4118_CR65","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.4049\/jimmunol.160.7.3305","volume":"160","author":"LI Pao","year":"1998","unstructured":"Pao, L. I., Famiglietti, S. J. & Cambier, J. C. Asymmetrical phosphorylation and function of immunoreceptor tyrosine-based activation motif tyrosines in B cell antigen receptor signal transduction. J. Immunol. 160, 3305\u20133314 (1998).","journal-title":"J. Immunol."},{"key":"4118_CR66","doi-asserted-by":"crossref","unstructured":"Smith, M. J. et al. Elevated PTEN expression maintains anergy in human B cells and reveals unexpectedly high repertoire autoreactivity. JCI Insight 4, e123384 (2019).","DOI":"10.1172\/jci.insight.123384"},{"key":"4118_CR67","doi-asserted-by":"publisher","first-page":"2133OIA94","DOI":"10.1083\/jcb.2133OIA94","volume":"213","author":"A Getahun","year":"2016","unstructured":"Getahun, A., Beavers, N. A., Larson, S. R., Shlomchik, M. J. & Cambier, J. C. Continuous inhibitory signaling by both SHP-1 and SHIP-1 pathways is required to maintain unresponsiveness of anergic B cells. J. Cell Biol. 213, 2133OIA94 (2016).","journal-title":"J. Cell Biol."},{"key":"4118_CR68","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1089\/ars.2011.4273","volume":"18","author":"Z Kovacevic","year":"2013","unstructured":"Kovacevic, Z., Chikhani, S., Lui, G. Y. L., Sivagurunathan, S. & Richardson, D. R. The iron-regulated metastasis suppressor NDRG1 targets NEDD4L, PTEN, and SMAD4 and inhibits the PI3K and ras signaling pathways. Antioxid. Redox Signal. 18, 874\u2013887 (2013).","journal-title":"Antioxid. Redox Signal."},{"key":"4118_CR69","doi-asserted-by":"crossref","unstructured":"Chung, I. C. et al. Src-family kinase-Cbl axis negatively regulates NLRP3 inflammasome activation. Cell Death Dis. 9, 1109 (2018).","DOI":"10.1038\/s41419-018-1163-z"},{"key":"4118_CR70","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.immuni.2004.07.013","volume":"21","author":"MS Jeon","year":"2004","unstructured":"Jeon, M. S. et al. Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction. Immunity 21, 167\u2013177 (2004).","journal-title":"Immunity"},{"key":"4118_CR71","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.immuni.2007.03.015","volume":"26","author":"Y Kitaura","year":"2007","unstructured":"Kitaura, Y. et al. Control of the B cell-intrinsic tolerance programs by ubiquitin ligases Cbl and Cbl-b. Immunity 26, 567\u2013578 (2007).","journal-title":"Immunity"},{"key":"4118_CR72","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0006-291X(03)00942-2","volume":"306","author":"Y Taketomi","year":"2003","unstructured":"Taketomi, Y. et al. Identification of NDRG1 as an early inducible gene during in vitro maturation of cultured mast cells. Biochem. Biophys. Res. Commun. 306, 339\u2013346 (2003).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"4118_CR73","doi-asserted-by":"publisher","first-page":"7042","DOI":"10.4049\/jimmunol.178.11.7042","volume":"178","author":"Y Taketomi","year":"2007","unstructured":"Taketomi, Y. et al. Impaired mast cell maturation and degranulation and attenuated allergic responses in Ndrg1-deficient mice. J. Immunol. 178, 7042\u20137053 (2007).","journal-title":"J. Immunol."},{"key":"4118_CR74","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1093\/brain\/awh275","volume":"127","author":"Y Parman","year":"2004","unstructured":"Parman, Y. et al. Clinicopathological and genetic study of early-onset demyelinating neuropathy. Brain 127, 2540\u20132550 (2004).","journal-title":"Brain"},{"key":"4118_CR75","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.nmd.2006.10.002","volume":"17","author":"A Echaniz-Laguna","year":"2007","unstructured":"Echaniz-Laguna, A. et al. NDRG1-linked Charcot-Marie-Tooth disease (CMT4D) with central nervous system involvement. Neuromuscul. Disord. 17, 163\u2013168 (2007).","journal-title":"Neuromuscul. Disord."},{"key":"4118_CR76","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/gim.2013.155","volume":"16","author":"Y Okamoto","year":"2014","unstructured":"Okamoto, Y. et al. Exonic duplication CNV of NDRG1 associated with autosomal-recessive HMSN-Lom\/CMT4D. Genet. Med. 16, 386\u2013394 (2014).","journal-title":"Genet. Med."},{"key":"4118_CR77","doi-asserted-by":"publisher","first-page":"9125","DOI":"10.1158\/0008-5472.CAN-07-1525","volume":"67","author":"P Zhang","year":"2007","unstructured":"Zhang, P., Tchou-Wong, K. M. & Costa, M. Egr-1 mediates hypoxia-inducible transcription of the NDRG1 gene through an overlapping Egr-1\/Sp1 binding site in the promoter. Cancer Res. 67, 9125\u20139133 (2007).","journal-title":"Cancer Res."},{"key":"4118_CR78","doi-asserted-by":"crossref","unstructured":"Collins, S. et al. Opposing regulation of T cell function by Egr-1\/NAB2 and Egr-2\/Egr-3. Eur. J. Immunol. 38, 528\u2013536. (2008)","DOI":"10.1002\/eji.200737157"},{"key":"4118_CR79","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1038\/s41590-020-0772-8","volume":"21","author":"N Burrows","year":"2020","unstructured":"Burrows, N. et al. Dynamic regulation of hypoxia-inducible factor-1\u03b1 activity is essential for normal B cell development. Nat. Immunol. 21, 1408\u20131420 (2020).","journal-title":"Nat. Immunol."},{"key":"4118_CR80","doi-asserted-by":"crossref","unstructured":"Meng, X. et al. Hypoxia-inducible factor-1\u03b1 is a critical transcription factor for IL-10-producing B cells in autoimmune disease. Nat. Commun. 9, 251 (2018).","DOI":"10.1038\/s41467-017-02683-x"},{"key":"4118_CR81","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/jbmr.2348","volume":"30","author":"J Chen","year":"2015","unstructured":"Chen, J., Holguin, N., Shi, Y., Silva, M. J. & Long, F. mTORC2 signaling promotes skeletal growth and bone formation in mice. J. Bone Miner. Res. 30, 369\u2013378 (2015).","journal-title":"J. Bone Miner. Res."},{"key":"4118_CR82","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1182\/blood-2013-01-477505","volume":"122","author":"K Lee","year":"2013","unstructured":"Lee, K. et al. Requirement for Rictor in homeostasis and function of mature B lymphoid cells. Blood 122, 2369\u20132379 (2013).","journal-title":"Blood"},{"key":"4118_CR83","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1016\/j.bbadis.2019.04.007","volume":"1865","author":"AM Merlot","year":"2019","unstructured":"Merlot, A. M. et al. The metastasis suppressor, NDRG1, differentially modulates the endoplasmic reticulum stress response. Biochim. Biophys. Acta Mol. Basis Dis. 1865, 2094\u20132110 (2019).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"4118_CR84","doi-asserted-by":"publisher","first-page":"9692","DOI":"10.1074\/jbc.M113.529511","volume":"289","author":"S Sahni","year":"2014","unstructured":"Sahni, S. et al. The metastasis suppressor, N-myc Downstream-regulated gene 1 (NDRG1), inhibits stress-induced autophagy in cancer cells. J. Biol. Chem. 289, 9692\u20139709 (2014).","journal-title":"J. Biol. Chem."},{"key":"4118_CR85","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/S0167-4889(99)00056-7","volume":"1450","author":"D Piquemal","year":"1999","unstructured":"Piquemal, D. et al. Differential expression of the RTP\/Drg1\/Ndr1 gene product in proliferating and growth arrested cells. Biochim. Biophys. Acta Mol. Cell Res. 1450, 364\u2013373 (1999).","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"4118_CR86","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1046\/j.1440-1711.1998.00709.x","volume":"76","author":"MJ Barnden","year":"1998","unstructured":"Barnden, M. J., Allison, J., Heath, W. R. & Carbone, F. R. Defective TCR expression in transgenic mice constructed using cDNA- based \u03b1- and \u03b2-chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 76, 34\u201340 (1998).","journal-title":"Immunol. Cell Biol."},{"key":"4118_CR87","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nbt.2647","volume":"31","author":"PD Hsu","year":"2013","unstructured":"Hsu, P. D. et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat. Biotechnol. 31, 827\u2013832 (2013).","journal-title":"Nat. Biotechnol."},{"key":"4118_CR88","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1231143","volume":"339","author":"L Cong","year":"2013","unstructured":"Cong, L. et al. Multiplex genome engineering using CRISPR\/Cas systems. Science 339, 819\u2013823 (2013).","journal-title":"Science"},{"key":"4118_CR89","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/s41590-018-0295-8","volume":"20","author":"C Anzilotti","year":"2019","unstructured":"Anzilotti, C. et al. An essential role for the Zn 2+ transporter ZIP7 in B cell development. Nat. Immunol. 20, 350\u2013361 (2019).","journal-title":"Nat. Immunol."},{"key":"4118_CR90","doi-asserted-by":"publisher","first-page":"3718","DOI":"10.1073\/pnas.1915247117","volume":"117","author":"X Xu","year":"2020","unstructured":"Xu, X. et al. An ontogenetic switch drives the positive and negative selection of B cells. Proc. Natl Acad. Sci. U.S.A. 117, 3718\u20133727 (2020).","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"4118_CR91","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"4118_CR92","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41590-019-0549-0","volume":"21","author":"L Abeler-D\u00f6rner","year":"2020","unstructured":"Abeler-D\u00f6rner, L. et al. High-throughput phenotyping reveals expansive genetic and structural underpinnings of immune variation. Nat. Immunol. 21, 86\u2013100 (2020).","journal-title":"Nat. Immunol."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-04118-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-04118-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-04118-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T19:37:53Z","timestamp":1678563473000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-04118-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,10]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["4118"],"URL":"https:\/\/doi.org\/10.1038\/s42003-022-04118-w","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,10]]},"assertion":[{"value":"22 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have declared that no competing interests exists, R.J.C. is a founder and shareholder in MIRO-Bio Ltd, K.R.B. is a consultant to D.J.S. antibodies Ltd.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1216"}}